Credit Suisse’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-73,902
| Closed | -$1.49M | – | 3772 |
|
|
2021
Q3 | $1.49M | Sell |
73,902
-14,440
| -16% | -$291K | ﹤0.01% | 2338 |
|
|
2021
Q2 | $3.3M | Buy |
88,342
+12,757
| +17% | +$476K | ﹤0.01% | 1833 |
|
|
2021
Q1 | $1.93M | Sell |
75,585
-32,843
| -30% | -$840K | ﹤0.01% | 2169 |
|
|
2020
Q4 | $2.39M | Buy |
108,428
+3,936
| +4% | +$86.7K | ﹤0.01% | 2015 |
|
|
2020
Q3 | $1.88M | Sell |
104,492
-6,373
| -6% | -$115K | ﹤0.01% | 1851 |
|
|
2020
Q2 | $2.82M | Buy |
110,865
+82,262
| +288% | +$2.09M | ﹤0.01% | 1630 |
|
|
2020
Q1 | $525K | Sell |
28,603
-44,570
| -61% | -$818K | ﹤0.01% | 2493 |
|
|
2019
Q4 | $1.61M | Buy |
73,173
+44,506
| +155% | +$980K | ﹤0.01% | 2211 |
|
|
2019
Q3 | $412K | Sell |
28,667
-9,373
| -25% | -$135K | ﹤0.01% | 2895 |
|
|
2019
Q2 | $600K | Sell |
38,040
-6,554
| -15% | -$103K | ﹤0.01% | 2679 |
|
|
2019
Q1 | $653K | Buy |
44,594
+16,574
| +59% | +$243K | ﹤0.01% | 2637 |
|
|
2018
Q4 | $299K | Buy |
28,020
+11,925
| +74% | +$127K | ﹤0.01% | 2992 |
|
|
2018
Q3 | $245K | Sell |
16,095
-4,126
| -20% | -$62.8K | ﹤0.01% | 3120 |
|
|
2018
Q2 | $247K | Buy |
+20,221
| New | +$247K | ﹤0.01% | 3233 |
|
|
2016
Q4 | – | Sell |
-10,245
| Closed | -$60K | – | 3835 |
|
|
2016
Q3 | $60K | Sell |
10,245
-43,867
| -81% | -$257K | ﹤0.01% | 3656 |
|
|
2016
Q2 | $163K | Buy |
+54,112
| New | +$163K | ﹤0.01% | 3633 |
|
|
2016
Q1 | – | Sell |
-15,886
| Closed | -$189K | – | 4000 |
|
|
2015
Q4 | $189K | Buy |
+15,886
| New | +$189K | ﹤0.01% | 3687 |
|
|
2015
Q3 | – | Sell |
-12,833
| Closed | -$179K | – | 4209 |
|
|
2015
Q2 | $179K | Buy |
+12,833
| New | +$179K | ﹤0.01% | 3970 |
|
|
2014
Q4 | – | Sell |
-12,536
| Closed | -$159K | – | 4303 |
|
|
2014
Q3 | $159K | Buy |
+12,536
| New | +$159K | ﹤0.01% | 3813 |
|